- The efficacy of monthly oral ibandronate (150 mg) is maintained: MOBILE Study long-term extensionPublikace bez p říslušnosti k fakultě
- Progressive efficacy improvements with quarterly intravenous ibandronate injections: the DIVA study long term extensionPublikace bez příslušnosti k fakultě
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)2015 | 1. lékařská fakulta
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial2023 | 1. lékařská fakulta
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial2016 | 1. lékařská fakulta
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial2016 | 1. lékařská fakulta
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | 1. lékařská fakulta
- Secukinumab v terapii psoriázy2016 | 3. lékařská fakulta
- Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate2020 | 1. lékařská fakulta
- Using multi-date high spectral resolution data to assess the physiological status of macroscopically undamaged foliage on a regional scale2014 | Přírodovědecká fakulta, Ústřední knihovna
- Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice2019 | 1. lékařská fakulta
- Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension2021 | 1. lékařská fakulta
- Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial2022 | 1. lékařská fakulta
- Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study2017 | 1. lékařská fakulta
- Setrvalá dlouhodobá účinnost a bezpečnost adalimumabu u dětských pacientů se závažnou chronickou ložiskovou psoriázou z randomizované, dvojitě zaslepené studie fáze III2020 | Lékařská fakulta v Plzni
- Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial2019 | 1. lékařská fakulta
